SATUDORA HOLDINGS CO., LTD. (JP:3544)
:3544
Top Page
SATUDORA HOLDINGS CO., LTD.
(3544)
Select Model
Select Model
Rating:61Neutral
Price Target:
¥869.00
▲(6.11% Upside)
Action:ReiteratedDate:11/01/25
SATUDORA HOLDINGS earns an overall score of 61, driven primarily by mixed financial performance with strong revenue growth offset by thin margins and moderate leverage. Reasonable valuation with a P/E of 15.61 and slight bullish short-term technical momentum provide support, though longer-term trends show resistance.
Positive Factors
Revenue Growth
The significant revenue growth indicates robust sales performance and market demand, supporting long-term business expansion and stability.
Negative Factors
High Leverage
High leverage can increase financial risk and limit flexibility, potentially impacting the company's ability to navigate economic downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The significant revenue growth indicates robust sales performance and market demand, supporting long-term business expansion and stability.
Read all positive factors
SATUDORA HOLDINGS CO., LTD. (3544) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥12.01B
Dividend Yield1.24%
Average Volume (3M)29.60K
Price to Earnings (P/E)12.7
Beta (1Y)0.27
Revenue Growth3.58%
EPS Growth-10.70%
CountryJP
Employees1,107
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)17.32
Shares Outstanding14,236,564
10 Day Avg. Volume15,720
30 Day Avg. Volume29,603
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)1.19
Price to Sales (P/S)0.12
P/FCF Ratio8.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SATUDORA HOLDINGS CO., LTD. Business Overview & Revenue Model
Company Description
Satudora Holdings Co., Ltd. primarily operates drug stores and dispensing pharmacies in Japan. It operates through Retail Business and IT Solution Business segments. The company also engages in the regional marketing business comprising EZOCA, a p...
How the Company Makes Money
SATUDORA HOLDINGS generates revenue through multiple streams, primarily from the sale of its core products in the technology and consumer goods sectors. This includes the manufacturing and distribution of electronics that cater to both domestic an...
SATUDORA HOLDINGS CO., LTD. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
50
Neutral
Cash Flow
60
Neutral
| Breakdown | TTM | May 2024 | May 2023 | May 2022 | May 2021 | May 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 100.56B | 100.17B | 95.52B | 87.48B | 82.91B | 83.24B |
| Gross Profit | 25.82B | 24.29B | 22.31B | 20.03B | 18.89B | 19.38B |
| EBITDA | 3.04B | 3.06B | 2.71B | 1.58B | 1.95B | 1.81B |
| Net Income | 732.00M | 768.00M | 470.00M | 87.00M | 317.00M | 575.00M |
Balance Sheet | ||||||
| Total Assets | 46.90B | 46.45B | 45.14B | 43.28B | 41.59B | 38.48B |
| Cash, Cash Equivalents and Short-Term Investments | 3.05B | 2.67B | 2.67B | 2.31B | 2.96B | 2.66B |
| Total Debt | 15.00B | 17.21B | 17.39B | 18.11B | 13.88B | 12.00B |
| Total Liabilities | 37.05B | 36.52B | 35.90B | 34.44B | 32.70B | 29.80B |
| Stockholders Equity | 9.72B | 9.80B | 9.13B | 8.73B | 8.80B | 8.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.32B | 2.10B | -3.81B | -602.00M | 1.26B |
| Operating Cash Flow | 0.00 | 2.60B | 3.54B | -1.77B | 1.28B | 3.37B |
| Investing Cash Flow | 0.00 | -1.67B | -1.92B | -2.87B | -2.23B | 1.20B |
| Financing Cash Flow | 0.00 | -935.00M | -1.26B | 4.00B | 1.27B | -3.39B |
SATUDORA HOLDINGS CO., LTD. Technical Analysis
Positive
819.00
Price Trends
858.36
Positive
838.07
Positive
835.60
Positive
Market Momentum
5.23
Negative
62.78
Neutral
93.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3544, the sentiment is Positive. The current price of 819 is below the 20-day moving average (MA) of 848.50, below the 50-day MA of 858.36, and below the 200-day MA of 835.60, indicating a bullish trend. The MACD of 5.23 indicates Negative momentum. The RSI at 62.78 is Neutral, neither overbought nor oversold. The STOCH value of 93.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3544.
SATUDORA HOLDINGS CO., LTD. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥677.19B | 23.29 | 15.71% | 0.96% | 21.81% | 67.76% | |
69 Neutral | ¥459.04B | 14.05 | 11.37% | 3.04% | 6.32% | 8.19% | |
67 Neutral | ¥366.97B | 16.82 | ― | 0.41% | 15.81% | 27.05% | |
62 Neutral | ¥1.01T | 19.41 | ― | 1.72% | ― | ― | |
61 Neutral | ¥12.01B | 12.70 | ― | 1.24% | 3.58% | -10.70% | |
60 Neutral | ¥524.40B | 22.79 | ― | 0.93% | 3.73% | 18.84% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:3544
SATUDORA HOLDINGS CO., LTD.
870.00
10.47
1.22%
JP:9989
Sundrug Co
3,926.00
-407.70
-9.41%
JP:7649
Sugi Holdings Co
3,593.00
714.54
24.82%
JP:3391
TSURUHA Holdings
2,250.00
211.69
10.39%
JP:3349
COSMOS Pharmaceutical Corporation
6,588.00
-1,376.79
-17.29%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,838.00
706.66
22.57%
SATUDORA HOLDINGS CO., LTD. Corporate Events
SATUDORA First-Half Profit Slides Despite Higher Sales, Full-Year Outlook Kept Intact
Dec 19, 2025
SATUDORA Holdings reported consolidated net sales of ¥50.3 billion for the first half of the fiscal year ending May 2026, up 1.3% year on year, but saw profitability weaken, with operating profit down 38.3% to ¥540 million and profit att...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.